Articles

The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes

Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Myelodysplastic Syndromes Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Myelodysplastic Syndromes Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Myelodysplastic Syndromes Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Myelodysplastic Syndromes Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Myelodysplastic Syndromes Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Myelodysplastic Syndromes Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Myelodysplastic Syndromes Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Myelodysplastic Syndromes Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Myelodysplastic Syndromes Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Myelodysplastic Syndromes Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China
Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Department of Pathology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China
Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China;Institute of Hematology, Zhejiang University, Hangzhou, China;Myelodysplastic Syndromes Diagnosis and Therapy Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Vol. 104 No. 3 (2019): March, 2019 https://doi.org/10.3324/haematol.2018.197749